10 April 2018
Vaper Expo is the biggest vape show in Europe taking place in Birmingham between 4th and 6th May 2018. This year, just like previously Chemnovatic will be displaying its range of products for e-liquid manufactures – pure nicotine, nicotine salts, nicotine bases, flavorings, additives etc.
As usual, we would love to invite you to visit our stand C110, meet the team and see how we can make your e-liquids better.
If you have any questions prior to the trade show, or would like to arrange a meeting please contact our representative on email@example.com.
1 March 2018
In December 2017 Chemnovatic has been subjected to the certification audit by TÜV Rheinland Polska Sp. z o. o., as a result we have been awarded the ISO 9001:2015, HACCP and GMP certificates.
We now have an integrated system of activities that ensure product safety and quality, minimizes human error and waste while increasing productivity.
You can find our certificates and read more about them here: https://chemnovatic.com/quality-process/
31 January 2018
We have introduced another e-liquid additive to our B2B platform – Sucralose.
Sucralose is nothing else than a synthetic sweetener used in the food industry (splenda). To give an example – Coca Cola and 4,000 other products are sweetened with sucralose, which is hidden under E955 designation. read more »
11 December 2017
Most vapers are still waiting for a long term study that would support the claims that e-liquids and vaping are much better for people than regular cigarettes. Now there is something we can actually show to the sceptics thanks to Dr. Riccardo Polosa.
Accoriding to a study that was recently presented on the E-Cigarette Summit in London and published in the Nature journal, vapers that have never smoked regular cigarettes experience no apparent long-term negative health effects from vaping.
Research group led by Dr. Riccardo Polosa measured coronary, respiratory and pulmonary vital signs in a group of young vapers with a 3.5 years vaping experience and no prior cigarette smoking history. Similar group of non vapers, no smokers was tested as well as a control group.
Scientists taken into consideration blood pressure, heart rate, exhaled carbon monoxide, high-resolution computed tomography (HRCT) of the lungs and many other aspects and found, that vaping had no negative health effects, it actually shown results to be identical to these of the non smokers, non vapers from the control group.
The results show no significant changes in lung function or structural abnormalities caused by daily exposure to electronic cigarettes. No changes in average heart rate or blood pressure was found even after 3.5 years of vaping – cigarette smokers show signs of lung damage after two years of smoking.
This is the first study showing long-term effects of vaping on people who have never smoked regular cigarettes and is great news for vapers and even better for cigarette smokers who now know that e-cigarettes are less harmful compared to regular cigarettes and a good way of smoking cessation despite the previous biased news stories.
14 November 2017
Next Generation Nicotine Delivery is an international conference on nicotine market trends, public health opinion and product innovation. This year it takes place for the 4th time, on the 14th and 15th November in London, UK.
Chemnovatic is attending the conference being a Roundtable sponsor with Marcin Górecki – our TPD specialist being one of the speakers.
You can find the conference programme here: http://cms.arena-international.com/Uploads/2017/11/13/u/l/f/Next-Generation-Nicotine-Delivery-13112017.pdf
As you can see, Marcin’s prelection on CLP and REACH influence on nicotine based products takes place tomorrow at 11:30, so you still have plenty of time to make it to London.